Skip to main content

Peer Review reports

From: Integrating trans-omics, cellular experiments and clinical validation to identify ILF2 as a diagnostic serum biomarker and therapeutic target in gastric cancer

Original Submission
26 Jan 2024 Submitted Original manuscript
5 Feb 2024 Reviewed Reviewer Report
13 Feb 2024 Reviewed Reviewer Report
15 Feb 2024 Reviewed Reviewer Report
25 Feb 2024 Author responded Author comments - Kun-He Zhang
Resubmission - Version 2
25 Feb 2024 Submitted Manuscript version 2
27 Feb 2024 Author responded Author comments - Kun-He Zhang
Resubmission - Version 3
27 Feb 2024 Submitted Manuscript version 3
7 Mar 2024 Reviewed Reviewer Report
10 Mar 2024 Reviewed Reviewer Report
17 Mar 2024 Reviewed Reviewer Report
Resubmission - Version 4
Submitted Manuscript version 4
Publishing
24 Mar 2024 Editorially accepted
15 Apr 2024 Article published 10.1186/s12885-024-12175-z

You can find further information about peer review here.

Back to article page